Jupiter Wellness, Inc. (JUPW)
Chart Events
Performance Outlook
| Previous Close | 1.3700 |
| Open | 1.3600 |
| Bid | 1.3400 x 900 |
| Ask | 1.3500 x 1100 |
| Day's Range | 1.3400 - 1.4000 |
| 52 Week Range | 1.2500 - 8.8800 |
| Volume | |
| Avg. Volume | 1,029,030 |
| Market Cap | 32.234M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.2500 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Related Research
- Jupiter Wellness, Inc.Daily – Vickers Top Buyers & Sellers for 10/08/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.RatingFair ValueEconomic Moat2 months agoArgus Research
- ACCESSWIRE
Jupiter Wellness Announces JW-300 Clinical Trial Results
JW-300 Demonstrates Efficacy in Treatment of Developing Burns (sunburn) in a Double-Blinded Placebo Controlled Clinical Trial.JUPITER, FL / ACCESSWIRE / November 16, 2021 / Jupiter Wellness, Inc.
- ACCESSWIRE
Jupiter Wellness Completes Pre-IND meeting with the U.S. Food & Drug Administration for JW-100 in the Treatment of Eczema
JUPITER, FL / ACCESSWIRE / November 11, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a clinical stage company developing cannabinoid receptor agonists for the treatment of eczema, actinic keratosis, burns, and herpes cold sores, announced that it has received an official written response from a Type B pre-Investigational New Drug (IND) meeting with the U.
- ACCESSWIRE
Jupiter Wellness Sponsors Jupiter Wellness Acquisition Corp SPAC Targeting AI Medical Therapeutics and Diagnostics
AI in medicine is projected to grow 18X from 2018 through 2025 to $35 billionJUPITER, FL / ACCESSWIRE / November 3, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced that it has filed a registration statement with the Securities and Exchange Commission to sponsor Jupiter Wellness Acquisition Corp.
